IPHA has welcomed the launch of yourmedicines.ie, a new patient-focused platform from medicines.ie that makes official Patient Information Leaflets (PILs) easier to find online. Trusted Medicines […]
Caitríona Duggan appointed President of the Irish Pharmaceutical Healthcare Association (IPHA) for a two-year term New research finds 90% of people believe timely access to […]
The Irish Pharmaceutical Healthcare Association (IPHA) has announced the appointment of Shane Ryan as its new Chief Executive. He will take up the role on 1 […]
Since July 2016, and in line with the IPHA Code of Practice for the Pharmaceutical Industry, companies have disclosed financial transfers of value (ToV)—whether direct or […]
Professor Michael Barry of the National Centre for Pharmacoeconomics made a number of unbalanced assertions on RTE Radio 1 last Sunday regarding suppliers of orphan medicines […]
Towards a Collaborative European Approach: Industry perspectives on access, innovation and coordination Joint statement from innovative pharmaceutical industry associations in the BeNeLuxA countries The national trade […]
The Irish Pharmaceutical Healthcare Association (IPHA) today welcomed encouraging growth in clinical trial activity in Ireland, while highlighting that system reforms are needed to ensure the […]
The access timelines for rare disease medicines have increased to 801 days from 685 days as reported last year. Average access timelines for all medicines […]
A new report shows Ireland’s pharmaceutical sector is of unprecedented economic importance and national strategic value. Conclusion of IPHA Framework Agreement is a new direction […]
